MLchartDataset catalogue

AP23573

Term · Oncology and biomedicine · MLC-T-ONC-000672

A substance being studied in the treatment of soft tissue and bone cancers. It is also being studied in the treatment of other solid tumors and hematologic cancer. AP23573 stops cells from dividing and may cause cancer cells to die. It is a type of mTOR inhibitor. Also called ridaforolimus.

Table 1. Record
IdentifierMLC-T-ONC-000672
FieldOncology and biomedicine
Expansionsridaforolimus
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000672",
  "term": "AP23573",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of soft tissue and bone cancers. It is also being studied in the treatment of other solid tumors and hematologic cancer. AP23573 stops cells from dividing and may cause cancer cells to die. It is a type of mTOR inhibitor. Also called ridaforolimus.",
  "expansions": [
    "ridaforolimus"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ap23573/"
}

Record 2,354 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.